Proterra Inc. (PTRA) Misses Q1 EPS by 82c

Proterra Inc. (NASDAQ: PTRA) reported Q1 EPS of ($1.08), $0.82 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $79.6 million versus the consensus estimate of $92.71 million.

For earnings history and earnings-related data on Proterra Inc. (PTRA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c